This suggests that alteration in YAP/TAZ upstream regulators (i.e., FAT1 and PIK3CA in HNSCC [24,27]) takes place during HNSCC tumor progression leading to the activation of these two co-transcriptional factors and their target genes [54]. The gene discussed is YAP1; the disease is head and neck squamous cell carcinoma.